AMG 378
/ Amgen
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 24, 2026
Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=48 | Terminated | Sponsor: Amgen | Recruiting ➔ Terminated | Trial primary completion date: Sep 2026 ➔ Jan 2026 | N=92 ➔ 48 | Trial completion date: Oct 2026 ➔ Jan 2026; Business Decision
Enrollment change • Trial completion date • Trial primary completion date • Trial termination
November 26, 2025
Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=92 | Recruiting | Sponsor: Amgen | Trial completion date: Oct 2028 ➔ Oct 2026 | Trial primary completion date: Oct 2028 ➔ Sep 2026
Trial completion date • Trial primary completion date
1 to 2
Of
2
Go to page
1